Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

33

Revenue 2017

Humalog

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humalog was produced by Lilly.

Lilly delivers upbeat earnings forecast for 2013

Lilly delivers upbeat earnings forecast for 2013 Current products such as Alimta and Cymbalta, as well as insulin product Humalog (insulin lispro) and Cialis (tadalafil) for erectile dysfunction, will support growth this year, said Lilly, as will expanded ... Humalog's $1.4bn in sales are also at risk

What Makes a Brand Iconic?

What Makes a Brand Iconic? HUMALOG. When it first launched in '96, Humalog was the wunderkind of biotechnology. ... Humalog underwent a brand repositioning and refresh to create a new attitude towards insulin.

Lilly launches branded app for emergency diabetes medicine

Although Glucagon is rarely needed, and as such is far from a headline product within Lilly's portfolio, diabetes is an important area for the company and its Humalog insulin was

Lilly’s income drops 5 per cent

The insulin, Humalog, also achieved high growth, with revenue up 20 per cent.

Profits down for Eli Lilly

Cymbalta (duloxetine) for depression; Alimta (pemetrexed) for non-small cell lung cancer, and type 1 diabetes treatment Humalog (insulin lispro) also had strong quarters with double digit growth.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

The challenges of identifying rare diseases
With increased awareness and improved diagnosis, more rare diseases are being recognised and this number is likely to increase in the coming years...
5 ways we’re enhancing our services to support our clients in 2023
Fishawack Health CEO Jon Koch explains the new platforms, tools, and services we’re elevating to drive innovation for our clients in 2023....
ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...